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Concentrating defect in experimental nephrotic syndrome: Altered ex-
pression of aquaporins and thick ascending limb Na1 transporters.
Background. Several pathophysiological states associated with deranged
water balance are associated with altered expression and/or intracellular
distribution of aquaporin water channels. The possible role of dysregula-
tion of thick ascending limb NaCl transporters, which are responsible for
countercurrent multiplication in the kidney, has not been evaluated.
Methods. Semiquantitative immunoblotting and immunocytochemistry
were carried out in the kidneys of rat with adriamycin-induced nephrotic
syndrome and in vehicle-injected control rats.
Results. Preliminary studies confirmed the presence of a severe concen-
trating defect. Semiquantitative immunoblotting of outer medullary ho-
mogenates demonstrated a marked decrease in the abundance of three
thick ascending limb Na1 transporters in nephrotic rats, namely the
bumetanide-sensitive Na-K-2Cl cotransporter (BSC-1), the type 3 Na/H
exchanger (NHE-3), and the a1-subunit of the Na-K-ATPase. These
results are predictive of a decrease in the NaCl transport capacity of the
medullary thick ascending limb and therefore a decrease in countercurrent
multiplication. Immunocytochemistry of outer medullary thin sections
demonstrated broad (but highly variable) suppression of BSC-1 expression
in the outer medullas of adriamycin-nephrotic rats. There was also a large
decrease in outer medullary expression of two collecting duct water
channels (aquaporin-2 and -3) and the major water channel of the thin
descending limb of Henle’s loop (aquaporin-1).
Conclusion. The concentrating defect in adriamycin-induced nephrotic
syndrome in rats is a consequence of multiple defects in water and solute
transporter expression, which would alter both the generation of medul-
lary interstitial hypertonicity and osmotic equilibration in the collecting
duct. Whether a similar widespread defect in transporter expression is
present in idiopathic nephrotic syndrome in humans is, at this point,
untested.
The availability of site-directed antibodies and cDNA
probes corresponding to the renal aquaporins has permit-
ted investigation of the molecular basis of dysregulation of
water excretion in animal models of several pathophysio-
logical states including congestive heart failure [1, 2],
hepatic cirrhosis [3, 4], nephrotic syndrome [5, 6], syn-
drome of inappropriate antidiuretic hormone secretion [3,
7], and several forms of acquired nephrogenic diabetes
insipidus [8–10]. These studies have focused on the role of
aquaporins in disordered collecting duct water absorption.
However, the ability of the kidney to conserve water is
dependent on more than just the water permeability of the
collecting duct in the presence of vasopressin. Specifically,
the urinary concentrating process is also dependent on
generation of a hypertonic medullary interstitium by coun-
tercurrent multiplication [11, 12]. Countercurrent multipli-
cation in the renal medulla is in turn dependent on active
absorption of NaCl by the medullary thick ascending limb
of Henle’s loop. In the present study, we investigated the
possible role of altered expression of Na1 transporters in
the thick ascending limb as a contributing factor in disor-
ders of the urinary concentrating mechanism. Here, we
focused on an animal model of the nephrotic syndrome,
adriamycin-induced nephrotic syndrome. Nephrotic syn-
drome has been demonstrated to be associated with a
urinary concentrating defect in both animals [5] and hu-
mans [13]. We investigated the effect of the adriamycin-
induced nephrotic state on the expression level of the three
major Na1 transporters of the medullary thick ascending
limb, namely the Na-K-2Cl cotransporter (termed either
“BSC-1” or “NKCC2”), which is apically located in the
apical plasma membrane [14, 15], the type 3 Na/H ex-
changer (NHE-3) that is also present in the apical plasma
membrane [16], and the a1 subunit of the Na-K-ATPase
found in the basolateral plasma membrane of thick ascend-
ing limb cells [17]. In addition, we re-examined the effect of
adriamycin-induced nephrotic syndrome on the expression
of aquaporins, focusing on the outer medullary expression
of aquaporins.
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METHODS
Antibodies
Rabbit polyclonal antibodies prepared against the thick
ascending isoform of the Na-K-2Cl cotransporter (BSC-1)
[15], aquaporin-1 [18], aquaporin-2 [19] and aquaporin-3
[20] have been described previously. They were raised
against keyhole limpet hemocyanin (KLH)-conjugated syn-
thetic peptides corresponding to hydrophilic portions of the
BSC-1 and aquaporin sequences in rat. The specificity of
each antibody has been demonstrated by showing unique
peptide-ablatable bands on immunoblots and a unique
distribution of labeling by immunohistochemistry and im-
munoelectron microscopy. These antibodies were affinity
purified against their respective immunizing peptides for
use in this study.
A mouse monoclonal antibody against Na-K-ATPase a1
subunit (Upstate Biotechnology, Lake Placid, NY, USA),
affinity-purified antibody to Tamm-Horsfall protein [21]
and a rabbit polyclonal antibody to NHE-3 raised in our
laboratory as previously described by Amemiya et al [16]
were also used. The specificity of the anti-NHE-3 antibody
was documented by immunoblotting showing a solitary 87
kD band (Fig. 1), and by immunofluorescence localization
in kidney sections (unpublished observations) showing api-
cal localization in the thick ascending limb and proximal
tubule exactly as described by Amemiya et al [16].
Animal model
This study used outer medullary and cortical samples
dissected from the same rats as described in our recent
study of adriamycin-induced nephrotic syndrome [5].
Briefly, pathogen-free male Sprague-Dawley rats (body wt
200 to 300 g; Breeding Facility, National Cancer Institute,
Frederick, MD, USA) were injected intravenously with
either adriamycin (7.5 mg/kg weight, doxorubicin hydro-
chloride; Sigma, St. Louis, MO, USA) dissolved in sterile
normal saline, or with the vehicle alone. The rats were
killed for immunochemical or morphological studies after
17 to 20 days, at a point which the adriamycin-injected rats
had developed full-blown nephrotic syndrome. Relative to
vehicle-injected controls, the adriamycin-treated rats exhib-
ited a 68-fold increase in the urinary excretion rate of total
protein, a ninefold increase in serum cholesterol, a 13-fold
increase in serum triglycerides, and a 540-fold increase in
intraperitoneal fluid content, documenting the develop-
ment of the nephrotic syndrome [6]. The urinary sodium
excretion rates were decreased from an average of 600
nEq/min in control rats to 81 nEq/min in adriamycin-
nephrotic rats, whereas the creatinine clearance averaged
1.37 6 0.13 ml/min in control rats, but only 0.68 6 0.12
ml/min in adriamcyin-nephrotic rats (P , 0.005) [6].
Urinary concentrating capacity
One group of adriamycin-injected rats and vehicle-in-
jected rats were utilized for measurements of urinary
concentrating capacity. For this, the rats were deprived of
water for 18 hours and then were given an injection of
aqueous arginine vasopressin (1 nmol/100 g body wt i.m.).
Spontaneously voided urine was collected 60 to 90 minutes
after the vasopressin injection for determination of osmo-
lality using a vapor pressure osmometer (Wescor Model
5100C; Wescor, Logan, UT, USA).
Kidney dissection and tissue preparation for
immunoblotting
After the rats were killed by decapitation and both
kidneys were rapidly removed, the cortices and outer
medullas were isolated. Each tissue sample was initially
homogenized for 15 seconds using a tissue homogenizer
(Omni 1000 fitted with a micro-sawtooth generator) in
ice-cold isolation solution containing 250 mM sucrose/10
mM triethanolamine (Calbiochem, La Jolla, CA, USA) with
1 mg/ml leupeptin (Bachem California, Torrance, CA,
USA) and 0.1 mg/ml phenylmethyl sulfonyl fluoride
(United States Biochemical Corporation, Toledo, OH,
USA). The total protein concentration in each sample was
measured using the Pierce BCA protein assay reagent kit.
The whole homogenates from the outer medulla and cortex
were used to study the regional distribution of the trans-
porter proteins.
Electrophoresis and immunoblotting of membrane
proteins
The samples were solubilized at 60°C for 15 minutes in
Laemmli sample buffer. Sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis was performed on 6% or 12%
polyacrylamide minigels, loading an equal amount of pro-
tein per lane. First, for each set of outer medullary and
cortical samples, an initial gel was stained with Coomassie
blue to confirm that equal loading had been achieved as
described previously [18]. Two to three prominent bands
were quantified by laser densitometry (Molecular Dynam-
ics model PDS1-P90) for each Coomassie-stained gel,
assuring that loading did not differ for any sample by more
than 10% from the mean. For immunoblotting, the proteins
were transferred from unstained gel electrophoretically to
nitrocellulose membranes. After being blocked with 5 g/dl
nonfat dry milk for 30 minutes, the blots were probed with
the antibodies to the Na1 transporters, aquaporins and
Tamm-Horsfall protein for 24 hours at 4°C. After washing,
the membranes were exposed to secondary antibody (don-
key anti-rabbit immunoglobulin G conjugated with horse-
radish peroxidase, Pierce no. 31458, diluted 1:5000 or goat
anti-mouse immunoglobulin G conjugated with horserad-
ish peroxidase, Pierce no. 31434, diluted 1:5000) for one
hour at room temperature. Sites of antibody-antigen reac-
tion were visualized using luminol-based enhanced chemi-
luminescence (Supersignal Substrate for Western blotting,
Pierce no. 34080). The appropriate band corresponding to
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each transporter was quantitated by densitometry (Molec-
ular Dynamics model PDS1-P90, ImageQuaNT v4.2 soft-
ware) for statistical analyis.
Morphological studies: Preparation of kidneys for light
microscopy examination
The living kidneys from control and adriamycin-treated
rats were preserved for microscopy by vascular perfusion
fixation. The rats were anesthetized with Inactin (Thio-
butalbarbital, 100 mg/kg body wt, intraperitoneally), were
secured to a dissecting table, and a laparotomy was per-
formed. The abdominal aorta was cannulated below the
renal arteries and, after the vena cava was severed, a
physiological saline solution (37°C) was perfused retro-
grade though the kidney at a pressure of 140 mm Hg. After
the kidneys were cleared of blood and without interruption
of perfusion pressure, a phosphate-buffered 2% glutaral-
dehyde solution (pH 7.2, 410 mOsm) was perfused though
the kidneys for approximately three minutes. Following
perfusion fixation, the samples were immersed in phos-
phate-buffered 2% glutaraldehyde overnight. For light
microscopy, thin sections (1 mm) of the fixed kidneys were
embedded in JB-4 media (Polysciences, Inc., methylene
blue, and basic fuchsin), and examined and photographed
using a Zeiss Axiophot.
Immunocytochemistry
Kidneys from Inactin-anesthetized adriamycin-nephrotic
and vehicle-injected control rats were fixed by vascular
perfusion through the abdominal aorta as described above,
except that the fixative was 0.1% glutaraldehyde plus 2%
paraformaldehyde in 0.1 M sodium cacodylate buffer, pH
7.2. The kidneys were post-fixed in the same solution for
two hours and then stored in 0.1 M cacodylate buffer, pH
7.2 at 4°C. Tissue blocks were prepared from outer me-
dulla. The blocks were infiltrated for 30 minutes with 2.3 M
sucrose containing 2% paraformaldehyde, mounted on
holders and rapidly frozen in liquid nitrogen, essentially as
described previously [7]. The frozen tissue blocks were
cryosectioned for immunohistochemistry. Cryosections of
thickness approximately 0.8 to 1 micrometer were obtained
with a Reichert Ultracut S Cryo-ultramicrotome and placed
on gelatin-coated glass slides. After preincubation with
phosphate-buffered saline (PBS) containing 1% bovine
serum albumin (BSA) or 0.1% skimmed milk and 0.05 M
glycine for five minutes, the sections were incubated over-
night at 4°C with the primary antibody diluted in PBS with
0.1% skim milk. Affinity-purified polyclonal anti-Na-K-2Cl
cotransporter was used at a concentration of 1 to 4 mg/ml.
The labeling was visualized by incubation for one hour at
room temperature with HRP-conjugated secondary anti-
body (P448 1:100; DAKO, Glostrup, Denmark), followed
by incubation with diaminobenzidine for 10 minutes. Sec-
tions were counterstained with Meier counterstain. The
following labeling controls were performed: (1) The pri-
mary antibody was substituted with non-immune rabbit IgG
purified on a protein A column; and (2) Incubations were
carried out without use of primary antibody, or without
primary and secondary antibodies. All controls revealed a
complete absence of labeling.
Presentation of data and statistical analyses
Quantitative data are presented as mean 6 standard
error of mean (SEM). Statistical comparisons were accom-
plished by unpaired t test (when variance were the same) or
by Mann-Whitney rank-sum test (when variances were
significantly different between groups). P values less than
0.05 were considered statistically significant.
RESULTS
Urinary concentrating capacity
As described above (under “Animal model” in the
Methods section), the adriamycin-injected rats developed
full-blown nephrotic syndrome with heavy proteinuria,
hyperlipidemia, and marked extracellular fluid retention
with ascites within 17 days of the injection. Urinary osmo-
lality was measured in three adriamycin-injected rats and
three vehicle-injected rats after 18 hours of water depriva-
tion and administration of synthetic vasopressin (1 nmol/
100 g body wt i.m.) to assess concentrating capacity. The
measurements were done 20 days after the adriamycin and
vehicle injections, after documentation of 41 proteinuria in
the adriamycin-injected rats (Albustixy, Bayer). The uri-
nary osmolality in the three vehicle-injected rats was
1825 6 448 mOsm/kg H2O. The urinary osmolality in the
adriamycin-treated rats was significantly lower (449 6 69
mOsm/kg H2O, P , 0.05).
Thick ascending limb Na1 transporter expression
Figure 1 shows immunoblots prepared from outer med-
ullary tissue homogenates and probed with antibodies to
three thick ascending limb Na1 transporters: (a) the thick
ascending limb form of Na-K-2Cl cotransporter, BSC-1
(Fig. 1A), (b) the a1 subunit of Na-K-ATPase (Fig. 1B),
and (c) the type 3 Na-H exchanger (NHE-3) (Fig. 1C). In
each immunoblot, each lane was loaded with a sample from
a different rat. Equality of loading among lanes was
confirmed by running parallel gels that were stained with
Coomassie blue to allow the intensity of several major
bands to be compared among samples (Methods).
Figure 1A shows the effect of the establishment of
adriamycin-induced nephrotic syndrome on the expression
of the Na-K-2Cl cotransporter (BSC-1). As previously seen
[15], the anti-Na-K-2Cl cotransporter antibody recognized
a broad band of molecular mass 146 to 176 kD (centered at
161 kD). There was a marked decrease in Na-K-2Cl
cotransporter expression in the outer medullas of the
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nephrotic rats. The densitometic analysis of the blots are
summarized in Table 1. In the outer medulla, the band
density for nephrotic rats averaged 17% of mean for the
controls.
Figure 1B shows the results from the same animals using
the anti-Na-K-ATPase a1 subunit antibody. In the outer
medulla, the predominant site of Na-K-ATPase expression
is the thick ascending limb. The expected molecular weight
for this protein is ;100 kD [22], consistent with the
mobility of the protein labeled with the antibody in the
present experiments. There was a marked decrease in
Na-K-ATPase expression in the outer medulla of nephrotic
rats. As summarized in Table 1, the band density of the the
a1 subunit of Na-K-ATPase in adriamycin-nephrotic rats
was decreased to 6% of control in the outer medulla.
Figure 1C shows the effect of establishment of adriamy-
cin-induced nephrotic syndrome on the expression of
NHE-3 in the outer medulla. This antibody recognized a
band of molecular mass 87 kD, consistent with previous
observations [16]. There was a marked decrease in NHE-3
expression in the outer medullas of nephrotic rats. As
shown in Table 1, the NHE-3 band density was decreased
to 33% of control.
Fig. 1. (A) Immunoblot of Na-K-2Cl cotransporter (BSC-1) in outer
medullas from control and adriamycin-nephrotic rats. Each lane was
loaded with a sample from a different rat (1 mg of total protein per lane).
(B) Immunoblot of Na-K-ATPase a1 subunit in outer medullas from
control and nephrotic rats; 0.5 mg of total protein were loaded per lane.
Membrane samples were from the same rats as those used for the top
panel. (C) Immunoblot of Na/H exchanger NHE-3 in outer medullas of
control and nephrotic rats; 5 mg of total protein were loaded per lane.
Membrane samples were from the same rats as those used for the others
two panels.
Fig. 2. Immunoblot of Na-K-2Cl cotransporter in cortex from control
and nephrotic rats. Each lane was loaded with a sample from a different
rat (5 mg of total protein per lane). Membrane samples were from the
same rats as those used for Figure 1.
Fig. 3. (A) Immunoblot of aquaporin-1 in outer medullas of control and
nephrotic rats. Two micrograms of total protein were loaded per lane.
Membrane samples were from the same rats as those used for Figure 1.
(B) Immunoblot of aquaporin-2 in outer medullas of control and ne-
phrotic rats; 3 mg of total protein were loaded per lane. Membrane
samples were from the same rats as those used for Figure 1. (C)
Immunoblot of aquaporin-3 in outer medullas of control and nephrotic
rats; 5 mg of total protein were loaded per lane. Membrane samples were
from the same rats as those used for Figure 1. (D) Immunoblot of
Tamm-Horsfall protein in outer medullas of control and adriamycin-
nephrotic rats; 5 mg of total protein were loaded per lane. Membranes
samples were from the same rats as those used for Figure 1.
Table 1. Densitometric analysis of immunoblots
Outer medulla
Na-K-2Cl cotransporter 17% 6 4%b
Na-K-ATPase a1 subunit 6% 6 2%b
NHE-3 33% 6 16%a
Aquaporin-1 30% 6 6%a
Aquaporin-2 34% 6 9%a
Aquaporin-3 40% 6 9%b
Tamm-Horsfall protein 18% 6 2%b
Values represent results in nephrotic rats expressed as a percent of the
mean for vehicle controls. Results are expressed as mean 6 SEM.
a P , 0.05, b P , 0.01 versus control rats
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Figure 2 shows expression in an immunoblot for the
Na-K-2Cl cotransporter in the cortex of nephrotic and
control rats. There was a marked decrease in the expression
of this transporter in the adriamycin-nephrotic rats. In fact,
the Na-K-2Cl cotransporter band density decreased to 15%
of the control in the cortex of nephrotic rats.
Expression of aquaporins in the outer medulla
Aquaporin-1 is expressed in the proximal tubule and
descending limb of Henle’s loop [23]. Figure 3A shows the
aquaporin-1 protein expression in immunoblot for outer
medullas of nephrotic and control rats. There are two
bands, one at 28 kD and a second one broad band at ;35
kD. The outer medullas of nephrotic rats had a significantly
decreased level of aquaporin-1 expression (Table 1).
Aquaporin-2 is the vasopressin-regulated water channel,
expressed in the apical plasma membrane and intracellular
vesicles of collecting duct principal cells [24]. Figure 3B
shows an immunoblot comparing aquaporin-2 protein ex-
pression in nephrotic and control rats in outer medulla.
Two bands were observed as demonstrated previously [24],
that is, one sharp band at 29 kD representing the nongly-
cosylated protein and one broad band representing the
glycosylated protein. In the outer medulla, the band density
of aquaporin-2 was significantly decreased in samples from
nephrotic rats relative to controls, averaging 34% of mean
for the controls (Table 1).
Aquaporin-3 is expressed in the basolateral membrane of
the collecting duct. Figure 3C shows results for outer
medullary samples from the same animals using the anti-
aquaporin-3 antibody. Two bands were observed as dem-
onstrated previously [20], one sharp band at 27 kD repre-
senting the nonglycosylated protein, and a broader band
representing the glycosylated protein. As seen with PAN-
induced nephrotic syndrome [5], there is a decrease in
aquaporin-3 expression in outer medulla with adriamycin-
induced nephrotic syndrome. As summarized in Table 1,
aquaporin-3 expression was decreased to 40% of control
levels in the outer medulla.
Tamm-Horsfall protein expression
The Tamm-Horsfall protein is a GPI-linked protein of
unknown function expressed virtually exclusively in the
thick ascending limb. Figure 3D shows results from an
immunoblot using a membrane samples from the renal
outer medulla of rats, probed with affinity-purified anti-
Tamm-Horsfall protein. This antibody recognized two
bands around 84 to 112 kD [15]. There was a marked
decrease in Tamm-Horsfall protein expression in outer
medulla from adriamycin-nephrotic rats. Tamm-Horsfall
band density was decreased to 18% of control levels in the
outer medulla (Table 1).
Morphological results
Figure 4 shows low magnification (Fig. 4A) and high
magnification (Fig. 4B) light micrographs of a hematoxylin
and eosin-stained thin section from the border between the
inner and outer stripes of the outer medulla of an adria-
mycin-nephrotic rat. Both proximal tubules (P) and thick
ascending limbs (D) showed heterogenous appearances
with some tubules displaying obstruction by casts (dark
lumina) and some tubules displaying an essentially normal
appearance (clear lumina).
Immunocytochemistry
Figure 5 shows immunocytochemical localization of the
bumetanide-sensitive Na-K-2Cl cotransporter in thin sec-
tions of the outer medulla of adriamycin-nephrotic and
Fig. 4. (A) Low magnification light microscopic section through the outer
medulla of a rat kidney preserved by vascular perfusion fixation seventeen
days following a single intravenous injection with adriamycin. While the
proximal tubules (P) and thick ascending limbs (D) of some nephrons are
filled with luminal casts other appear close to normal in their morpholog-
ical appearance. Abbreviations are: IS, inner stripe of outer medulla; OS,
outer stripe of outer medulla. Bar 5 100 mm. (B) Higher magnification
view of the region of the inner stripe surrounded by brackets in A. Bar 5
50 mm.
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Fig. 5. Immunoperoxidase labeling of bumetanide-sensitive Na-K-2Cl cotransporter (BSC-1) in 0.9 mm cryosections of kidneys from vehicle-injected
control (A and B) and adriamycin-nephrotic (C–E) rats. Sections are from the inner stripe of the outer medulla (A, D) and from the junction between
the inner and outer stripe of the outer medulla (B, C, E). A and B. In kidneys from control animals, thick ascending limb cells (T) exhibit uniformly
strong apical labeling for BSC-1 (arrows). The asterisk in panel B indicates the transition of a proximal tubule into a descending thin limb. C and D.
In adriamycin-nephrotic rats, relatively strong BSC-1 labeling is associated with some thick ascending limbs (arrows, T), whereas other thick ascending
limbs display much less labeling (tubule labeled T in panel D) or virtually no labeling (cells indicated by arrowheads). E. Immunolabeling control
(non-immune IgG as primary antibody) reveal no labeling (31,000).
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vehicle-injected control rats. As previously described [14,
15], in normal control rats (Fig. 5 A, B), the cotransporter
was localized to the apical region of thick ascending limb
cells with relatively even distribution among cells in indi-
vidual tubules and relatively uniform labeling among thick
ascending limbs. In the outer medullas of adriamycin-
nephrotic rats, labeling was generally weaker, although the
apical distribution was maintained. There was considerable
variability of labeling among thick ascending limbs. Some
thick ascending limbs showed labeling nearly as intense as
seen in controls (Fig. 5C; tubule labeled “T”) while others
showed markedly reduced labeling (arrowheads in Fig. 5 C,
D). Figure 5E is an immunolabeling control using non-
immune IgG in lieu of the anti-BSC-1 antibody.
Consistent with previous evidence [25], the proximal
tubule cells exhibited distinct vacuolization. This is seen in
Figure 5C, where two cross-sectioned proximal tubules
(upper left corner of Fig. 5C; one is indicated with P) have
multiple vacuoles in the cytoplasm. In addition, a distinct
vacuolization was observed in some thick ascending limb
cells (for example, the TAL cells indicated by arrowhead in
Fig. 5C).
DISCUSSION
A defect in urinary concentrating capacity has been
documented in nephrotic syndrome, both in experimental
nephrotic syndrome in rats [5] and in humans with idio-
pathic nephrotic syndrome [13]. To investigate the molec-
ular basis of the concentrating defect in an experimental
model of the nephrotic syndrome, we set up a well-
established animal model, namely the adriamycin-induced
nephrotic syndrome in rats [26]. After documenting the
presence of a severe concentrating defect, we carried out
semiquantiative immunoblotting studies demonstrating
that adriamycin-induced nephrotic syndrome manifests a
decrease in the expression level of thick ascending limb
Na1 transporters and a decrease in the expression levels of
the major renal medullary aquaporin water channels. The
physiological significance of these changes is discussed
below.
In the normal state, urine is concentrated as a result of
the combined functions of the loop of Henle and collecting
duct. The loop of Henle generates a high osmolality in the
renal medulla by driving the countercurrent multiplication
process. The collecting duct, when vasopressin is present,
permits osmotic equilibration between the urine and the
hypertonic medullary interstitium. The development of a
high osmolality in the renal medulla is dependent on net
NaCl absorption by the thick ascending limb. Here we
demonstrate marked decreases in the expression levels of
three thick ascending limb Na1 transporters in adriamycin-
induced nephrotic syndrome. Working in tandem, these
transporters (the apically expressed Na-K-2Cl cotrans-
porter BSC-1, the apically expressed Na/H exchanger
NHE-3, and the basolaterally expressed Na-K-ATPase a1
subunit) are responsible for sodium absorption by the thick
ascending limb. Suppressed expression of these transport-
ers would be expected to result in decreased active NaCl
absorption by the thick ascending limb and is therefore
predictive of decreased countercurrent multiplication of
NaCl in rats with adriamycin-induced nephrotic syndrome.
Thus, based on the data of the present paper, we postulate
that the concentrating defect in nephrotic syndrome is in
part due to decreased countercurrent multiplication sec-
ondary to decreased Na1 transporter expression in the
thick ascending limb.
For assessment of transporter expression, we used a
semiquantitative immunoblotting approach. The immuno-
blotting samples were homogenates from the inner stripes
of the outer medullas dissected from the kidneys of adria-
mycin-nephrotic and vehicle-treated rats. Since BSC-1 is
virtually exclusively expressed in thick ascending limbs, the
immunoblotting approach gives a direct means of assessing
relative expression of the BSC-1 protein. Similarly, the
approach gives a direct means of assessing thick ascending
limb expression of NHE-3, since this protein is found
virtually exclusively in thick ascending limbs at the level of
the inner stripe of the outer medulla [16]. In contrast to
BSC-1 and NHE-3, the Na-K-ATPase is expressed in all
renal tubule segments [27, 28]. However, among renal
tubule segments, Na-K-ATPase activity is highest in the
outer medullary thick ascending limb [11] accounting for
approximately 90% of the total Na-K-ATPase activity in
the outer medulla. Thus, the decrease seen in Na-K-
ATPase expression in the outer medullas of adriamycin-
nephrotic rats must be attributable to a decrease in its
expression in the thick ascending limb. The Na-K-ATPase
is of course responsible for active transport of sodium ions
from the cell to the peritubular environment, and therefore
furnishes overall driving force for transepithelial NaCl
transport in the thick ascending limb.
Outer medullary expression of aquaporin-1 was also
significantly decreased in adriamycin-nephrotic rats, sug-
gesting that the water-absorbing capacity of the descending
limb may be impaired. Osmotic equilibration in the de-
scending limb of Henle’s loop is critical to the efficient
functioning of the countercurrent multiplier [11]. There-
fore, a decline in aquaporin-1 may contribute to a decrease
in medullary solutes by limiting the degree of osmotic
equilibration in the thin descending limb.
Previously, using the adriamycin model [6], two addi-
tional observations were made that may also contribute to
the defect in urinary concentration capacity associated to
nephrotic syndrome: (1) a decline in aquaporin-2 and -3
expression in the collecting ducts, and (2) a decline in
expression of the vasopressin regulated urea chanel in the
inner medulla. The reduction in aquaporin-2 and -3 expres-
sion was confirmed in this study. Such a decrease in
collecting duct water channel expression can be expected to
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result in impairment of water absorption from the collect-
ing duct under antidiuretic conditions [5]. The decrease in
water channel expression might be due in part to the
“vasopressin-escape” phenomenon. Recently, it has been
demonstrated that the escape from inappropriately high
circulating vasopressin levels is attributable, at least in part,
to a vasopressin-independent decrease in aquaporin-2 wa-
ter channel expression in the renal collecting duct [7]. In
addition, the decrease in the expression of the vasopressin-
regulated urea transporter, demonstrated previously [6],
would predict reduced urea transfer into the inner medul-
lary interstitium and presumably reduce urea accumulation
in the inner medulla. Thus, we conclude that the concen-
trating defect in this model of the nephrotic syndrome is a
consequence of multiple defects in transporter expression
that would alter both the generation of medullary intersti-
tial hypertonicity and osmotic equilibration in the collect-
ing duct. Whether a similar widespread defect in trans-
porter expression is present in idiopathic nephrotic
syndrome in humans is, at this point, untested.
The cause of the decrease in BSC-1, NHE-3 and Na-K-
ATPase expression in the outer medullary thick ascending
limb of adriamycin-nephrotic rats is not ascertainable from
the present results. Microscopic study of the outer medulla
reveals that some of the thick ascending limbs have casts in
the lumen while others appear normal (Fig. 4). This
heterogeneous picture is consistent with both physiological
[29] and morphological [30] studies of the experimentally-
induced nephrotic syndrome, indicating that only a fraction
of the nephrons leak copious amounts of protein giving
heterogeneous downstream effects. Conceivably mechani-
cal forces due to tubule obstruction could alter gene
expression in the thick ascending limb. Recent evidence
suggests that the distortion of the plasma membrane can
activate various signaling pathways in various cell types
including renal epithelia [31]. In addition, immunocyto-
chemistry using an anti-BSC-1 antibody showed decreased
expression of BSC-1 in thick ascending limbs, with greater
variability of expression than seen in control rats, suggest-
ing that local factors, rather than globally-exerted factors,
may in part be responsible for the down-regulation of
BSC-1 in the outer medulla. It is also very possible that the
decrease in transporter expression in this experimental
model is a direct effect of adriamycin on the renal tubule
epithelial cells. The mechanism by which this agent pro-
duces obliteration of the foot processes of glomerular
podocytes is not known, but the effect presumably involves
impairment of the vesicle trafficking processes involved in
maintaining the complex shape of these cells. It appears
possible that the decline in ion transporter and water
channel expression induced by adriamycin is a consequence
of a similar impairment of trafficking in renal tubule cells.
Consistent with this possibility, light microscopic examina-
tion of thin sections of outer medulla revealed a substantial
degree of vacuolization in thick ascending limb cells (Fig.
5C), similar to changes previously described in glomerular
epithelial cells and proximal tubules of adriamycin-treated
rabbits [25]. Further studies will be needed to investigate
the mechanistic basis of this abnormality. Since similar
histopathological changes are not generally seen in ne-
phrotic syndrome in humans, the significance of these
observations to human disease is uncertain. Such vacuol-
ization, was not however seen in collecting ducts of adria-
mycin-treated rats [6]. Consequently, the reported de-
creases in aquaporin-2 and -3 expression seen in
adriamycin-induced nephrotic syndrome are not associated
with vacuolization.
A defect in urinary diluting capacity has also been
reported in nephrotic syndrome [32–35]. The urinary dilut-
ing process depends on generation a hypotonic luminal
fluid by the cortical thick ascending limb of Henle’s loop
through active NaCl transport via the apical Na-K-2Cl
cotransporter. It also depends on the maintenance of a low
water permeability throughout the distal tubule and collect-
ing duct system. The observed decrease in collecting duct
water channel expression would theoretically predict a low
water permeability rather than a high water permeability in
the collecting duct, compatible with maintenance of dilut-
ing capacity. The present study, however, shows a decrease
in Na-K-2Cl cotransporter expression in the cortical thick
ascending limb. The decrease in Na-K-2Cl cotransporter
expression may provide an explanation for the defect in
diluting capacity observed in nephrotic syndrome, since
NaCl transport in the cortical portion of the thick ascend-
ing limb of Henle’s loop is responsible for tubule fluid
dilution. In addition, a reduction in glomerular filtration
rate may also affect the urinary diluting capacity by reduc-
ing the amount of tubular fluid delivered to the distal
nephron. The creatinine clearance data obtained in the
present studies and in similary treated rats in an earlier
study [36] suggest that adriamycin-induced nephrotic syn-
drome is associated with a substantial reduction in glomer-
ular filtration rate.
Sodium retention is a cardinal feature in nephrotic
syndrome. Indeed, we observed a marked decrease in
sodium excretion in rats with adriamycin-induced nephrotic
syndrome relative to controls. Neither the renal site nor the
mechanism of this antinatriuresis is well known. An overall
decrease in sodium excretion and a concomitant expansion
of extracellular fluid volume is seen in this experimental
model despite a decrease in expression of apical and
basolateral Na1 transporters in the thick ascending limb.
Theoretically, with such a profound decrease in sodium
transporter expression in the thick ascending limb, the
expected outcome might be expected to be an increase in
sodium excretion, just as is seen when bumetanide or other
loop diuretics inhibit sodium transport in the thick ascend-
ing limb. Presumably, the predicted natriuresis did not
occur because of an intact tubuloglomerular feedback
mechanism which would be expected to stabilize distal
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delivery of NaCl by decreasing glomerular filtration rate.
This mechanism appears likely based on the observed
decrease in glomerular filtration rate in these animals.
Additional studies will be required to determine whether
NaCl contransporters elsewhere along the renal tubule are
up-regulated to provide an additional mechanism to com-
pensate for decreased thick ascending limb NaCl absorp-
tion.
In summary, adriamycin induced-nephrotic syndrome in
rats has been demonstrated to be associated with a marked
down-regulation of expression of the three major Na1
transporters in the medullary thick ascending limb of
Henle’s loop. These observations, combined with demon-
strated decreases in vasopressin-regulated urea transporter
expression [6]] and aquaporin water channel expression,
provide an explanation for the concentrating defect seen in
adriamycin-induced nephrotic syndrome. The presence of
such defects in transporter expression remains to be tested
in human nephrotic syndrome.
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